Comparison of the fatal @entity137 index of @entity9038 with XXXX .

@entity137 @entity9038 @entity1245 @entity1401 @entity2794 @entity34022 @entity204 @entity130
BACKGROUND: @entity9038 is a hypnosedative structurally unrelated to the @entity1245 but operating at the same receptor complex. Although @entity9038 has been used in clinical practice for many years, relatively little is known of its relative @entity137 in comparison with other hypnosedatives. METHOD: Deaths, where hypnosedatives were implicated, in New Zealand (NZ) in 2001 were identified from a @entity130 database. Prescription and aggregate @entity2794 ( @entity2794 ) data forNZ in 2001 were obtained from a national prescribing database. Rates of @entity204 per prescription and @entity2794 , and relative rates between individual hypnosedatives and @entity1245 , and their respective 95% CI were calculated. RESULTS: Of the 200 @entity204 in NZ for 2001, 39 involved hypnosedatives, and @entity9038 was involved in 12. Hypnosedatives were the sole agents in only one @entity204 and were the primary agents in eight deaths. @entity9038 was the sixth most commonly involved agent in @entity204 in NZ in 2001. The relative rate of @entity204 per prescription (95% CI) and @entity2794 (95% CI) of @entity9038 compared with @entity1245 were 1.04 (0.49-2.05) and 0.59 (0.28-1.16), respectively. The relative rates of @entity204 per @entity2794 (95% CI) for @entity1401 and @entity34022 compared with the other sedatives/anxiolytics were 6.2 (1.6-17.0) and 20.9 (2.5-79.8) respectively. CONCLUSIONS: The fatal @entity137 for @entity9038 was not significantly different from that for @entity1245 as a group when adjusted for usage, whereas @entity1401 and @entity34022 had greater @entity137 . Hypnosedatives are contributory factors rather than primary substances in @entity204 .
